Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Paschke

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Applied Microbiology and Biotechnology|December 21, 2005
Phage display systems and their applicationsMatthias Paschke
Gene|March 30, 2005
A twin-arginine translocation (Tat)-mediated phage display systemMatthias Paschke, Wolfgang Höhne
Journal of Molecular Recognition : JMR|October 9, 2007
Engineering a circularly permuted GFP scaffold for peptide presentationMatthias Paschke, Christian Tiede, Wolfgang Höhne
New Biotechnology|May 28, 2008
SRP and Sec pathway leader peptides for antibody phage display and antibody fragment production in E. coliHolger Thie, Thomas Schirrmann, Matthias Paschke, et al.
Investigative Ophthalmology & Visual Science|May 26, 2007
Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesisFelix Bock, Jasmine Onderka, Tina Dietrich, et al.
Journal of Medicinal Chemistry|June 26, 2009
Novel small molecule bradykinin B2 receptor antagonistsChristoph Gibson, Karsten Schnatbaum, Jochen R Pfeifer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 21, 2024
Preclinical Characterization of DPI-4452: A <sup>68</sup>Ga/<sup>177</sup>Lu Theranostic Ligand for Carbonic Anhydrase IXFrédéric Massière, Norbert Wiedemann, Inês Borrego, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 22, 2026
Preclinical Development of 3BP-3940, a Fibroblast Activation Protein-Targeted Cyclic Peptide-Based Radiotheranostic for Imaging and TherapyDirk Zboralski, Frank Osterkamp, Jan L von Hacht, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 22, 2023
Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibitionDirk Zboralski, Frank Osterkamp, Esben Christensen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 24, 2022
Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapyDirk Zboralski, Aileen Hoehne, Anne Bredenbeck, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Applied Microbiology and Biotechnology|December 21, 2005
Phage display systems and their applicationsMatthias Paschke
Gene|March 30, 2005
A twin-arginine translocation (Tat)-mediated phage display systemMatthias Paschke, Wolfgang Höhne
Journal of Molecular Recognition : JMR|October 9, 2007
Engineering a circularly permuted GFP scaffold for peptide presentationMatthias Paschke, Christian Tiede, Wolfgang Höhne
New Biotechnology|May 28, 2008
SRP and Sec pathway leader peptides for antibody phage display and antibody fragment production in E. coliHolger Thie, Thomas Schirrmann, Matthias Paschke, et al.
Investigative Ophthalmology & Visual Science|May 26, 2007
Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesisFelix Bock, Jasmine Onderka, Tina Dietrich, et al.
Journal of Medicinal Chemistry|June 26, 2009
Novel small molecule bradykinin B2 receptor antagonistsChristoph Gibson, Karsten Schnatbaum, Jochen R Pfeifer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 21, 2024
Preclinical Characterization of DPI-4452: A <sup>68</sup>Ga/<sup>177</sup>Lu Theranostic Ligand for Carbonic Anhydrase IXFrédéric Massière, Norbert Wiedemann, Inês Borrego, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 22, 2026
Preclinical Development of 3BP-3940, a Fibroblast Activation Protein-Targeted Cyclic Peptide-Based Radiotheranostic for Imaging and TherapyDirk Zboralski, Frank Osterkamp, Jan L von Hacht, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 22, 2023
Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibitionDirk Zboralski, Frank Osterkamp, Esben Christensen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 24, 2022
Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapyDirk Zboralski, Aileen Hoehne, Anne Bredenbeck, et al.
Pageof 1